Genetic variation in angiotensin-converting enzyme-related pathways associated with sudden cardiac arrest risk

Heart Rhythm

Volumn 6, Issue 9, 2009, Pages 1306-1314

  Sotoodehnia, Nona ^a   Li, Guo ^a   Johnson, Catherine O ^a   Lemaitre, Rozenn N ^a   Rice, Kenneth M ^b   Rea, Thomas D ^a,b   Siscovick, David S ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSINOGEN; BRADYKININ B2 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; KININOGEN; RENIN; AGTR1 PROTEIN, HUMAN;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; EUROPEAN AMERICAN; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEART ARREST; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES; AGED; CASE CONTROL STUDY; CONFIDENCE INTERVAL; DEATH, SUDDEN, CARDIAC; EMBRYOLOGY; GENETICS; HEART ARRHYTHMIA; METABOLISM; MIDDLE AGED; RISK; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; ARRHYTHMIAS, CARDIAC; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; DEATH, SUDDEN, CARDIAC; FEMALE; GENETIC VARIATION; HUMANS; KININOGENS; MALE; MIDDLE AGED; ODDS RATIO; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RISK ASSESSMENT; RISK FACTORS; WASHINGTON;

EID: 68949200176     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2009.06.013     Document Type: Article

References (35)

1. Zheng Z.J., Croft J.B., Giles W.H., and Mensah G.A. Sudden cardiac death in the United States, 1989 to 1998. Circulation 104 (2001) 2158-2163
2. Friedlander Y., Siscovick D.S., Arbogast P., et al. Sudden death and myocardial infarction in first degree relatives as predictors of primary cardiac arrest. Atherosclerosis 162 (2002) 211-216
3. Ferreira A.J., Santos R.A., and Almeida A.P. Angiotensin-(1-7): cardioprotective effect in myocardial ischemia/reperfusion. Hypertension 38 (2001) 665-668
4. Linz W., Scholkens B.A., and Han Y.F. Beneficial effects of the converting enzyme inhibitor, ramipril, in ischemic rat hearts. J Cardiovasc Pharmacol 8 Suppl 10 (1986) S91-S99
5. Yahiro E., Ideishi M., Wang L.X., et al. Reperfusion-induced arrhythmias are suppressed by inhibition of the angiotensin II type 1 receptor. Cardiology 99 (2003) 61-67
6. Rajani V., Hussain Y., Bolla B.S., et al. Attenuation of epinephrine-induced dysrhythmias by bradykinin: role of nitric oxide and prostaglandins. Am J Cardiol 80 (1997) 153A-157A
7. Parikh N.I., Gona P., Larson M.G., et al. Plasma renin and risk of cardiovascular disease and mortality: the Framingham Heart Study. Eur Heart J 28 (2007) 2644-2652
8. Kober L., Torp-Pedersen C., Carlsen J.E., et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. N Engl J Med 333 (1995) 1670-1676
9. Pitt B., Zannad F., Remme W.J., et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341 (1999) 709-717
10. Yusuf S., Sleight P., Pogue J., Bosch J., Davies R., and Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342 (2000) 145-153
11. Sullivan J.C. Sex and the renin-angiotensin system: inequality between the sexes in response to RAS stimulation and inhibition. Am J Physiol Regul Integr Comp Physiol 294 (2008) R1220-R1226
12. Siscovick D.S., Raghunathan T.E., King I., et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 274 (1995) 1363-1367
13. Malik F.S., Lavie C.J., Mehra M.R., Milani R.V., and Re R.N. Renin-angiotensin system: genes to bedside. Am Heart J 134 (1997) 514-526
14. Keidar S., Kaplan M., and Gamliel-Lazarovich A. ACE2 of the heart: From angiotensin I to angiotensin (1-7). Cardiovasc Res 73 (2007) 463-469
15. Moreau M.E., Garbacki N., Molinaro G., Brown N.J., Marceau F., and Adam A. The kallikrein-kinin system: current and future pharmacological targets. J Pharmacol Sci 99 (2005) 6-38
16. Carlson C.S., Eberle M.A., Rieder M.J., Yi Q., Kruglyak L., and Nickerson D.A. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 74 (2004) 106-120
17. Kasi V.S., Xiao H.D., Shang L.L., et al. Cardiac-restricted angiotensin-converting enzyme overexpression causes conduction defects and connexin dysregulation. Am J Physiol Heart Circ Physiol 293 (2007) H182-H192
18. Xiao H.D., Fuchs S., Campbell D.J., et al. Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death. Am J Pathol 165 (2004) 1019-1032
19. Donoghue M., Wakimoto H., Maguire C.T., et al. Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins. J Mol Cell Cardiol 35 (2003) 1043-1053
20. Yoshida H., Zhang J.J., Chao L., and Chao J. Kallikrein gene delivery attenuates myocardial infarction and apoptosis after myocardial ischemia and reperfusion. Hypertension 35 (2000) 25-31
21. Shang L.L., Sanyal S., Pfahnl A.E., et al. NF-kappaB-dependent transcriptional regulation of the cardiac scn5a sodium channel by angiotensin II. Am J Physiol Cell Physiol 294 (2008) C372-C379
22. Daleau P., and Turgeon J. Angiotensin II modulates the delayed rectifier potassium current of guinea pig ventricular myocytes. Pflugers Arch 427 (1994) 553-555
23. Chen L.M., Chung P., Chao S., Chao L., and Chao J. Differential regulation of kininogen gene expression by estrogen and progesterone in vivo. Biochim Biophys Acta 1131 (1992) 145-151
24. Bouhnik J., Savoie F., Michaud A., Baussant T., Alhenc-Gelas F., and Corvol P. Effect of sex hormones on plasma T-kininogen in the rat. Life Sci 44 (1989) 1859-1866
25. Anderson K.P., and Lingrel J.B. Glucocorticoid and estrogen regulation of a rat T-kininogen gene. Nucleic Acids Res 17 (1989) 2835-2848
26. Lee PH, Shatkay H. Two birds, one stone: selecting functionally informative tag SNPs for disease association studies. In: Algorithms in Bioinformatics. Proceedings of the 7th International Workshop, WABI 2007, Philadelphia, PA, USA, September 8-9, 2007. Volume 4645/2007. Berlin/Heidelberg: Springer, 2007:61-72.
27. Raizada V., Skipper B., Luo W., et al. Renin-angiotensin polymorphisms and QTc interval prolongation in end-stage renal disease. Kidney Int 68 (2005) 1186-1189
28. Anvari A., Turel Z., Schmidt A., et al. Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphism in coronary disease and malignant ventricular arrhythmias. Cardiovasc Res 43 (1999) 879-883
29. Bleumink G.S., Schut A.F., Sturkenboom M.C., Deckers J.W., van Duijn C.M., and Stricker B.H. Genetic polymorphisms and heart failure. Genet Med 6 (2004) 465-474
30. Miller J.A., and Scholey J.W. The impact of renin-angiotensin system polymorphisms on physiological and pathophysiological processes in humans. Curr Opin Nephrol Hypertens 13 (2004) 101-106
31. Mottl A.K., Shoham D.A., and North K.E. Angiotensin II type 1 receptor polymorphisms and susceptibility to hypertension: a HuGE review. Genet Med 10 (2008) 560-574
32. Ntzani E.E., Rizos E.C., and Ioannidis J.P. Genetic effects versus bias for candidate polymorphisms in myocardial infarction: case study and overview of large-scale evidence. Am J Epidemiol 165 (2007) 973-984
33. Pereira T.V., Nunes A.C., Rudnicki M., Yamada Y., Pereira A.C., and Krieger J.E. Meta-analysis of the association of 4 angiotensinogen polymorphisms with essential hypertension: a role beyond M235T?. Hypertension 51 (2008) 778-783
34. Bedi M., McNamara D., London B., and Schwartzman D. Genetic susceptibility to atrial fibrillation in patients with congestive heart failure. Heart Rhythm 3 (2006) 808-812
35. Ravn L.S., Benn M., Nordestgaard B.G., et al. Angiotensinogen and ACE gene polymorphisms and risk of atrial fibrillation in the general population. Pharmacogenet Genomics 18 (2008) 525-533